Mammary epithelial cell development is thought to progress from undifferentiated stem cells into at least two differentiated cell types. A new study has now characterized some of these distinct developmental stages and links them to tumor subtypes previously defined by gene expression profiling (pages 907–913).
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Neuropilin-1 is over-expressed in claudin-low breast cancer and promotes tumor progression through acquisition of stem cell characteristics and RAS/MAPK pathway activation
Breast Cancer Research Open Access 25 January 2022
-
The association of women’s birth size with risk of molecular breast cancer subtypes: a cohort study
BMC Cancer Open Access 23 March 2021
-
Prolactin receptor-driven combined luminal and epithelial differentiation in breast cancer restricts plasticity, stemness, tumorigenesis and metastasis
Oncogenesis Open Access 14 January 2021
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Katie Vicari
References
Perou, C.M. et al. Nature 406, 747–752 (2000).
Lim, E. et al. Nat. Med. 15, 907–913 (2009).
Livasy, C.A. et al. Mod. Pathol. 19, 264–271 (2005).
Schneider, B.P. et al. Clin. Cancer Res. 14, 8010–8018 (2008).
Ginestier, C. et al. Cell Stem Cell 1, 555 (2007).
Herschkowitz, J.I. et al. Genome Biol. 8, R76 (2007).
Hennessy, B.T. et al. Cancer Res. 69, 4116–4124 (2009).
Nielsen, T.O. et al. Clin. Cancer Res. 10, 5367–5374 (2004).
Raouf, A. et al. Cell Stem Cell 3, 109–118 (2008).
Foulkes, W.D. J. Med. Genet. 41, 1–5 (2004).
Liu, S. et al. Proc. Natl. Acad. Sci. USA 105, 1680–1685 (2008).
Diehn, M. et al. Nature 458, 780 (2009).
Carey, L.A. et al. Clin. Cancer Res. 13, 2329–2334 (2007).
Li, X. et al. J. Natl. Cancer Inst. 100, 672–679 (2008).
Creighton, C. et al. Proc. Natl. Acad. Sci. USA (in the press).
Cristofanilli, M. et al. N. Engl. J. Med. 351, 781–791 (2004).
Chung, C.H., Bernard, P. & Perou, C. Nat. Genet. 32 Suppl, 533–540 (2002).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Prat, A., Perou, C. Mammary development meets cancer genomics. Nat Med 15, 842–844 (2009). https://doi.org/10.1038/nm0809-842
Issue Date:
DOI: https://doi.org/10.1038/nm0809-842
This article is cited by
-
Neuropilin-1 is over-expressed in claudin-low breast cancer and promotes tumor progression through acquisition of stem cell characteristics and RAS/MAPK pathway activation
Breast Cancer Research (2022)
-
The association of women’s birth size with risk of molecular breast cancer subtypes: a cohort study
BMC Cancer (2021)
-
Prolactin receptor-driven combined luminal and epithelial differentiation in breast cancer restricts plasticity, stemness, tumorigenesis and metastasis
Oncogenesis (2021)
-
Co-expression of carcinoembryonic antigen-related cell adhesion molecule 6 and 8 inhibits proliferation and invasiveness of breast carcinoma cells
Clinical & Experimental Metastasis (2019)
-
C1orf106, an innate immunity activator, is amplified in breast cancer and is required for basal-like/luminal progenitor fate decision
Science China Life Sciences (2019)
